NCT02151240View on ClinicalTrials.gov

Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster

PHASE4CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

July 31, 2019

Conditions
Herpes Zoster
Interventions
DRUG

Foscarnet Sodium

DRUG

Acyclovir

Trial Locations (1)

100044

Peking University People's Hospital, Beijing

All Listed Sponsors
collaborator

Peking University People's Hospital

OTHER

lead

Cttq

INDUSTRY

NCT02151240 - Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster | Biotech Hunter | Biotech Hunter